DR Reddy S Laboratories Limited — Valsartan Exporter Profile
Indian Pharmaceutical Exporter · #15 for Valsartan · $9.1M export value · DGFT Verified
DR Reddy S Laboratories Limited is the #15 Indian exporter of Valsartan with $9.1M in export value and 18 verified shipments. DR Reddy S Laboratories Limited holds a 0.5% market share in Valsartan exports across 1 countries. The company exports 50 pharmaceutical products worth $310.6M across 19 therapeutic categories.
DR Reddy S Laboratories Limited — Valsartan Export Profile: Buyers & Destinations
Where Does India Export Valsartan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $50.0M | 1,001 | 50.8% |
| HUNGARY | $6.8M | 136 | 6.9% |
| IRAQ | $6.7M | 186 | 6.8% |
| BELGIUM | $5.6M | 635 | 5.7% |
| SLOVENIA | $4.8M | 96 | 4.9% |
| GERMANY | $4.7M | 94 | 4.8% |
| FRANCE | $4.0M | 208 | 4.1% |
| UNITED KINGDOM | $3.3M | 66 | 3.3% |
| CANADA | $3.3M | 100 | 3.3% |
| PHILIPPINES | $2.2M | 180 | 2.2% |
India exports Valsartan to 119 countries. The top destination is UNITED STATES (50.8%), followed by HUNGARY and IRAQ.
Who Are the Top Buyers of Valsartan from India?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MYLAN PHARMACEUTICALS INC, | UNITED STATES | $4.7M | 93 |
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $4.5M | 187 |
| MYLAN HUNGARY KFT, | HUNGARY | $4.5M | 90 |
| J. KNIPPER & COMPANY | UNITED STATES | $4.4M | 104 |
| MYLAN PHARMACEUTICALS INC | UNITED STATES | $3.5M | 69 |
| LEK D.D | SLOVENIA | $3.4M | 67 |
| MACLEODS PHARMA USA,INC | UNITED STATES | $3.0M | 59 |
| MACLEODS PHARMA USA ,INC | UNITED STATES | $2.4M | 48 |
| M/S. MYLAN PHARMACEUTICALS INC, | UNITED STATES | $1.6M | 31 |
| NEXTPHARMA LOGISTICS GMBH | GERMANY | $550.0K | 11 |
India's Valsartan is purchased by 663 buyers worldwide. The top buyer is MYLAN PHARMACEUTICALS INC, (UNITED STATES), followed by YUSEN LOGISTICS BENELUX BELGIUM and MYLAN HUNGARY KFT,.
What Is India's Total Valsartan Export Value and How Much Does DR Reddy S Laboratories Limited Contribute?
India exported $113.6M worth of Valsartan through 6,098 shipments from 259 suppliers to 119 countries, serving 663 buyers globally. DR Reddy S Laboratories Limited contributes $9.1M to this total, accounting for 0.5% of India's Valsartan exports.
What Is the Average Shipment Value for DR Reddy S Laboratories Limited's Valsartan Exports?
DR Reddy S Laboratories Limited's average Valsartan shipment value is $502.8K per consignment, based on 18 shipments totaling $9.1M.
How Does DR Reddy S Laboratories Limited Compare to Other Indian Valsartan Exporters?
DR Reddy S Laboratories Limited ranks #15 among 259 Indian Valsartan exporters with a 0.5% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($28.9M), MACLEODS PHARMACEUTICALS LTD ($27.9M), ALEMBIC PHARMACEUTICALS LIMITED ($10.5M). DR Reddy S Laboratories Limited processed 18 shipments to 1 destination countries.
Regulatory Requirements: Exporting Valsartan to Key Markets
What DR Reddy S Laboratories Limited must comply with to export Valsartan to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does DR Reddy S Laboratories Limited Compare to Nearest Valsartan Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | ZYDUS LIFESCIENCES LIMITED | $1.4M | 64 | 7 | $21.7K |
| 14 | DR REDDYS LABORATORIES LIMITED | $1.4M | 30 | 3 | $45.7K |
| 15 | DR REDDY S LABORATORIES LIMITED ★ | $900.0K | 18 | 1 | $50.0K |
DR Reddy S Laboratories Limited ranks #15 among 259 Indian Valsartan exporters. Average shipment value of $50.0K compared to the market average of $438.5K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and DR REDDYS LABORATORIES LIMITED.
Which Indian Ports Ship Valsartan Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 946 | 15.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 707 | 11.6% |
| DELHI AIR CARGO ACC (INDEL4) | 627 | 10.3% |
| DELHI AIR | 516 | 8.5% |
| NHAVA SHEVA SEA (INNSA1) | 445 | 7.3% |
| JNPT/ NHAVA SHEVA SEA | 323 | 5.3% |
| JNPT | 213 | 3.5% |
| MUNDRA SEA | 176 | 2.9% |
What Other Cardiovascular Products Does DR Reddy S Laboratories Limited Export?
DR Reddy S Laboratories Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on DR Reddy S Laboratories Limited's Valsartan Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Dr. Reddy's. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. Dr. Reddy's, with its established presence and compliance with stringent regulatory standards, is well-positioned to capitalize on this shift.
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Dr. Reddy's commitment to quality and regulatory adherence ensures its continued access to the EU market, despite the evolving regulatory landscape.
DR Reddy S Laboratories Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for Dr. Reddy's. The company has consistently adhered to FDA, WHO, and EU Good Manufacturing Practices (GMP), ensuring the quality and safety of its products. This commitment is crucial in sustaining trust and credibility in global markets.
However, regulatory challenges persist. In April 2025, Dr. Reddy's received a show cause notice from the Indian Income Tax Department concerning a proposed demand of over ₹2,395 crore related to the merger of Dr. Reddy's Holding Ltd with itself. The company has stated its belief that there is no tax liability arising from the merger and is addressing the matter through appropriate channels. (business-standard.com)
About DR Reddy S Laboratories Limited
DR Reddy S Laboratories Limited exports 50 products worth $310.6M. Beyond Valsartan, top products include Metoprolol, Omeprazole, Fexofenadine, Clopidogrel, Esomeprazole. View the complete DR Reddy S Laboratories Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Valsartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Valsartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: DR Reddy S Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 119+ countries, 663+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Valsartan Export Data from DR Reddy S Laboratories Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for DR Reddy S Laboratories Limited's Valsartan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
DR Reddy S Laboratories Limited
Full Company Profile →
50 products · $310.6M total trade · 19 categories
Valsartan Stats
Company Overview
Top Products by DR Reddy S Laboratories Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for DR Reddy S Laboratories Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Valsartan. For current shipment-level data, contact TransData Nexus.